Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
60/100
Pipeline Velocity
25/100
Trial Completion Rate
100/100
Pipeline Concentration
100/100
Pipeline Freshness
72/100
Activity
Last 14 days
Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in the Jumping Gap of Immediately Placed Implant: A Randomized Clinical Study
Clinical and Microbiological Evaluation of Aloe Vera Gel and Clindamycin Gel as an Adjunct to Non-Surgical Treatment of Periodontitis: A Comparative Study
Effect of Autologous Demineralized Dentin Graft With or Without Melatonin Gel on the Osseo Integration of Immediately Placed Implants: A Randomized Clinical Study
Assessment of Flapless Piezo-surgery Technique Versus Conventional Open Flap Technique for Aesthetic Crown Lengthening: A Randomized Controlled Clinical Trial
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)